Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Apr 21, 2023; 29(15): 2322-2335
Published online Apr 21, 2023. doi: 10.3748/wjg.v29.i15.2322
Table 2 Comparison of clinical data among groups, n (%)
Variable
Group I (n = 105)
Group II (n = 175)
Group III (n = 139)
Group IV (n = 86)
F/χ2
P
Clinical feature
Haematemesis6 (5.7)12 (6.9)16 (11.5)16 (18.6)11.588 0.009
Edema2 (1.9)12 (6.9)20 (14.4)33 (38.4)65.284 < 0.001
SBP 1 (1.0)4 (2.3)11 (7.9)13 (15.1)23.486 < 0.001
Hyponatremia 3 (2.9)21 (12.0)31 (22.3)31 (36.0)42.806 < 0.001
Hepatic encephalopathy5 (4.8)10 (5.7)14 (10.1)19 (22.1)21.565 < 0.001
Refractory ascites2 (1.9)4 (2.3)15 (10.8)21 (24.4)44.367 < 0.001
Jaundice 12 (11.4)13 (7.4)15 (10.8)20 (23.3)14.120 0.003
MELD score8.74 ± 1.548.64 ± 1.5717.04 ± 1.96a,b25.19 ± 2.15a,b,c2081.425< 0.001
Laboratory index
RDW (%)12.54 ± 0.8513.29 ± 1.19a14.3 ± 1.96a,b16.25 ± 2.13a,b,c101.958< 0.001
TBIL (μmol/L)12.3 (10.9, 13.45)11.5 (9.8, 14.5)12.8 (10.7, 17.5)b16.3 (13.18,24.95)a,b,c57.344< 0.001
ALB (g/L)45.91 ± 3.8344.92 ± 5.19a37.85 ± 4.71a,b33.50 ± 5.65a,b,c159.072< 0.001
ALT (IU/L)24 (18, 32)27 (21, 34)a32 (23, 37)a,b35 (26, 75)a,b,c40.591< 0.001
AST (IU/L)26 (19.5, 33)28 (21, 35)30 (22, 36)a34 (25, 62)a,b25.257< 0.001
γ-GT (IU/L)32 (20, 44)30 (22, 41)35 (26, 43)37 (26, 47)a,b14.960.002
ALP (IU/L)65 (52, 84)74 (53, 88)69 (54, 87)69 (58, 84)3.5350.316
WBC count (× 109/L)5.64 ± 1.515.36 ± 1.405.76 ± 1.16b6.10 ± 1.55a,b5.6950.001
Hemoglobin (g/L)122.86 ± 15.53121.10 ± 15.30107.92 ± 16.33a,b99.28 ± 18.15a,b,c52.186< 0.001
Platelet count (× 109/L)190.15 ± 62.47174.98 ± 41.71a101.09 ± 27.46a,b90.38 ± 32.33a,b165.715< 0.001
INR0.91 (0.59, 1.27)1.21 (0.61, 1.80)a1.58 (0.86, 2.41)a,b1.37 (1.17, 2.22)a,b57.797< 0.001
NT-proBNP (pg/mL)72 (61, 84)76 (61, 98)354 (127, 653)a,b647 (364, 1430)a,b,c242.974< 0.001
eGFR (ml/min/1.73 m2)62.35 ± 11.0960.87 ± 13.5259.07 ± 15.9443.31 ± 11.39a,b,c40.691< 0.001
Drug information
Diuretic 3 (2.9)7 (4)20 (14.4)32 (37.2)69.996 < 0.001
Spirolactone 3 (2.9)7 (4)17 (12.2)26 (30.2)50.491 < 0.001
ACEI/ARB 7 (6.7)23 (13.1)22 (15.8)23 (26.7)15.690 0.001
β-blocker 6 (5.7)13 (7.4)23 (16.5)22 (25.6)23.776 < 0.001